B

Bispebjerg Hospital | Dermatologisk Afdeling

Research site
(Unclaimed)
Location
Bispebjerg Bakke 23, Nielsine Nielsens Vej, opgang 9, Copenhagen, Hovedstaden, Denmark
Site insights

Top conditions

Heart Failure (8 trials)

Stroke (8 trials)

Ulcer (6 trials)

Hernia (6 trials)

Tendinopathy (5 trials)

Top treatments

Dexamethasone
Ropivacaine
Rimegepant
Adalimumab
TD-9855
CP-690,550
Ustekinumab
somatropin
AGMB-129
Sepranolone

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

7 of 181
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study (CutDM-MealBox)

The cornerstone in the initial treatment of type 2 diabetes (T2D) is lifestyle modification, involving-among other things-a healthy diet. However, sc...

Active, not recruiting
Diabetes Mellitus Type 2
Overweight and Obesity
Other: Carbohydrate-reduced high-protein (CRHP) Diet
Other: Conventional diabetes (CD) Diet

The objective is to compare the efficacy and safety of masitinib in combination with riluzole versus matched placebo in combination with riluzole for...

Enrolling
Amyotrophic Lateral Sclerosis
Drug: Placebo
Drug: Masitinib (4.5)

This study is being conducted to evaluate the efficacy and tolerability of rimegepant in a population of adults that are unsuitable for triptan medic...

Enrolling
Migraine
Drug: Rimegepant
Drug: Placebo

This study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate...

Enrolling
Migraine
Drug: Rimegepant
Drug: Placebo
Locations recently updated

This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and sy...

Enrolling
MSA - Multiple System Atrophy
Symptomatic Neurogenic Orthostatic Hypotension
Drug: Placebo
Drug: Ampreloxetine

Actinic keratosis (AK), also known as solar keratosis, is a common skin condition characterised by abnormal growth of skin cells caused by long-term...

Active, not recruiting
Actinic Keratoses
Drug: AVX001

Many patients with Crohn's disease develop fibrotic narrowing (strictures) in their bowel, causing obstructive symptoms such as abdominal pain, cramp...

Enrolling
Fibrostenotic Crohn's Disease
Drug: Placebo
Drug: AGMB-129

Trial sponsors

B

Bispebjerg Hospital (72 trials)

Pfizer logo

Pfizer (6 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems